Acumen Hypotension Prediction Index EV1000 Clinical Platform vs CINA CHEST

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index EV1000 Clinical Platform

by Edwards Lifesciences

CINA CHEST

by Avicenna.AI

AI Verdict

These tools are adjacent rather than direct competitors, as they address different clinical problems within critical care and emergency settings. Acumen HPI focuses on predicting and managing hemodynamic instability, specifically hypotension, through continuous physiological monitoring. CINA CHEST, conversely, specializes in the rapid AI-powered detection and triage of acute conditions like Pulmonary Embolism and Aortic Dissection from CT angiography scans.

Choose Acumen Hypotension Prediction Index EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary goal is proactive management and prevention of intraoperative or critical care hypotension. This tool excels at providing real-time, predictive insights into a patient's hemodynamic stability, allowing clinicians to intervene before hypotensive events occur. It's ideal for continuous monitoring in settings where maintaining stable blood pressure is paramount.

View Acumen Hypotension Prediction Index EV1000 Clinical Platform →

Choose CINA CHEST if…

Choose CINA CHEST if your priority is to rapidly triage and detect life-threatening conditions like Pulmonary Embolism and Aortic Dissection from CT angiography scans in an emergency radiology setting. This AI-powered solution streamlines workflow by flagging suspected positive findings, enabling quicker diagnosis and prioritization of critical cases. It is best suited for enhancing the efficiency and accuracy of emergency radiological interpretations.

View CINA CHEST →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index EV1000 Clinical Platform	CINA CHEST
Pricing	Unknown	Subscription-based
Deployment	On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform)	Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)
FDA Status	Cleared AI-estimated	K210237 AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index EV1000 Clinical Platform	CINA CHEST
Tool Name	Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform	CINA CHEST
Company	Edwards Lifesciences	Avicenna.AI
Primary Function	Predicts hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension.	AI-powered radiological triage and notification software, designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans.
Prediction/Detection Target	Hypotensive events	Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans
Technology	Machine learning-based algorithm	Artificial intelligence (deep learning algorithms)
Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology, Emergency Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index EV1000 Clinical Platform and CINA CHEST.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into the existing clinical workflow for real-time patient management (Tool A) versus diagnostic imaging interpretation and triage (Tool B)?

Acumen HPI (Tool A) integrates directly into the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, providing continuous, real-time hemodynamic insights and predictive alerts at the patient's bedside for proactive intervention. CINA CHEST (Tool B) operates as a standalone web application, providing AI-powered radiological triage and notifications for suspected PE and AD on CT scans to assist in prioritizing diagnostic interpretation.

What is the depth of integration with our electronic health record (EHR) system for automated data transfer, result documentation, or clinical decision support?

Acumen HPI (Tool A) is integrated with the Edwards Lifesciences HemoSphere platform, suggesting data flow within that monitoring ecosystem. CINA CHEST (Tool B) provides notifications with preview images, and while it assists in workflow triage, the extent of automated data transfer or direct documentation into an EHR beyond these notifications would need further clarification.

What are the reported accuracy, sensitivity, and specificity metrics for predicting hypotension (Tool A) or detecting PE/AD (Tool B) in relevant patient populations?

Acumen HPI (Tool A) uses a machine learning-based algorithm to predict hypotension up to 15 minutes in advance, providing an HPI Parameter (0-100 likelihood score) and Smart Alerts for trending hypotension. CINA CHEST (Tool B) is designed for rapid detection and prioritization of PE and AD on CT angiography scans, flagging and communicating suspected positive findings.

What is the typical learning curve for clinical staff to become proficient with each tool, and what is the estimated time to achieve measurable clinical benefits?

For Acumen HPI (Tool A), clinicians would need to learn to interpret the HPI score, Smart Alerts, and Relationship View for hemodynamic insights. For CINA CHEST (Tool B), radiologists and emergency physicians would learn to interpret the AI-flagged notifications for PE and AD to prioritize their workflow effectively.

Beyond standard compliance, what advanced security features and audit-trail capabilities are offered to ensure data integrity, user accountability, and transparency of AI-driven insights?

While both tools are HIPAA compliant, the provided information does not detail specific advanced security features beyond this, such as granular access controls, encryption protocols, or comprehensive audit-trail functionalities for tracking AI-influenced clinical decisions.

For a multi-site hospital system, what are the key considerations for implementing and scaling each solution, particularly regarding hardware, network, and training across different facilities?

Acumen HPI (Tool A) requires integration with the Edwards Lifesciences HemoSphere platform via dedicated sensors (Acumen IQ cuff or sensor), implying hardware and infrastructure considerations for each site. CINA CHEST (Tool B) operates as a standalone web application, which may offer more flexible deployment options for scaling across multiple sites, though network and training for radiologists would still be key.

How does each tool specifically support clinical decision-making within its target specialties to directly impact patient outcomes?

Acumen HPI (Tool A) supports anesthesiologists, critical care, and emergency medicine by predicting hypotension and providing insights into its causes, enabling proactive intervention to reduce intraoperative hypotension. CINA CHEST (Tool B) assists radiologists, cardiologists, and emergency medicine by rapidly detecting and prioritizing life-threatening PE and AD, facilitating quicker diagnosis and treatment.